Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Abruptly attenuated terminal ictal pattern in pediatrics.
Durable responses in acute lymphoblastic leukaemia with the use of FLT3 and IDH inhibitors.
Management of important adverse events associated with inotuzumab ozogamicin: expert panel review.
Treatment of young adults with Philadelphia-negative acute lymphoblastic leukemia and lymphoblastic lymphoma: Hyper-CVAD vs. pediatric-inspired regimens.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Management of important adverse events associated with inotuzumab ozogamicin: expert panel review.
Management of important adverse events associated with inotuzumab ozogamicin: expert panel review. Bone Marrow Transplant. 2018 04; 53(4):449-456.
View in:
PubMed
subject areas
Antibodies, Monoclonal, Humanized
Clinical Trials as Topic
Disease Management
Febrile Neutropenia
Hepatic Veno-Occlusive Disease
Humans
Practice Guidelines as Topic
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Risk Factors
Salvage Therapy
Tumor Lysis Syndrome
Vascular Diseases
authors with profiles
Wendy Stock
Koen Van Besien